scPharmaceuticals Inc. (SCPH) NASDAQ

$5.10 -0.01 (-0.20%)

Market Cap: $139.59M

As of 05/25/22 04:30 PM EDT. Market closed.

(SCPH)

scPharmaceuticals Inc. (SCPH) NASDAQ

$5.10 -0.01 (-0.20%)

Market Cap: $139.59M

As of 05/25/22 04:30 PM EDT. Market closed.

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the ... read more

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
John Tucker
Full Time Employees
27
CEO Compensation (Base)
$494,227
CEO Compensation (Total)
$1.49M
URL
Address
2400 District Ave Ste 310, Massachusetts, Burlington, 01803-5239.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
John Tucker
Full Time Employees
27
CEO Compensation (Base)
$494,227
CEO Compensation (Total)
$1.49M
Address
2400 District Ave Ste 310, Massachusetts, Burlington, 01803-5239.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$5.11
Days Range
$5.07 - $5.13
52 week range
$3.48 - $7.28
Volume
4,963
Avg. Volume (30 days)
17,648
Market Cap
$139.59M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
27,371,488
Open
$0
Previous Close
$5.11
Days Range
$5.07 - $5.13
52 week range
$3.48 - $7.28
Volume
4,963
Avg. Volume (30 days)
17,648
Market Cap
$139.59M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
27,371,488

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SCPHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
5AM Partners IV, LLC 10% Owner Apr 11, 2022 Sale $5.00 40,733 203,665 537,301 Apr 13, 2022, 04:51 PM
5AM Partners IV, LLC 10% Owner Apr 11, 2022 Sale $5.00 9,171 45,855 120,966 Apr 13, 2022, 04:51 PM
5AM Partners IV, LLC 10% Owner Apr 11, 2022 Sale $5.00 220,096 1,100,480 2,903,207 Apr 13, 2022, 04:51 PM
Khattar Jack A. Director Dec 03, 2021 Buy $3.91 5,000 19,569 5,000 Dec 06, 2021, 05:55 PM
Tucker John H President and CEO Dec 03, 2021 Buy $3.96 10,000 39,553 46,962 Dec 06, 2021, 05:53 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Mar 12, 2021 Sale $7.22 39,469 284,816 2,838,034 Mar 16, 2021, 04:30 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Mar 15, 2021 Sale $7.03 110,588 777,787 2,727,446 Mar 16, 2021, 04:30 PM
Tucker John H President and CEO Jun 30, 2020 Option Exercise $7.36 10,288 75,720 36,962 Jul 02, 2020, 12:00 AM
Schwab Andrew J. 10% Owner May 26, 2020 Buy $8.65 578,034 4,999,994 578,034 May 28, 2020, 09:12 PM
ORBIMED ADVISORS LLC 10% Owner May 21, 2020 Buy $8.65 1,387,283 11,999,997 4,565,948 May 26, 2020, 04:44 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Feb 14, 2020 Buy $8.20 271,993 2,230,343 3,518,998 Feb 21, 2020, 04:46 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Feb 14, 2020 Buy $8.20 271,993 2,230,343 3,247,005 Feb 19, 2020, 12:00 AM
Tucker John H President and CEO Dec 13, 2019 Buy $5.24 5,000 26,188 5,000 Dec 17, 2019, 04:16 PM
RA CAPITAL MANAGEMENT, LLC 10% Owner Apr 11, 2019 Buy $2.70 389,862 1,052,627 3,247,005 Apr 15, 2019, 04:31 PM
Agger Mette Kirstine Director Nov 21, 2017 Buy $14.00 654,762 9,166,668 3,183,986 Feb 13, 2018, 05:38 PM
SCHAEFFER LEONARD D Director Dec 19, 2017 Option Exercise $1.66 22,631 37,567 57,449 Dec 20, 2017, 04:18 PM
SUN PHARMACEUTICAL INDUSTRIES LTD 10% Owner Nov 21, 2017 Buy $14.00 357,143 5,000,002 357,143 Nov 24, 2017, 04:33 PM
Lundbeckfond Invest A/S 10% Owner Nov 21, 2017 Buy $14.00 654,762 9,166,668 3,183,986 Nov 21, 2017, 07:24 PM
5AM Partners IV, LLC 10% Owner Nov 21, 2017 Buy $14.00 26,190 366,660 130,135 Nov 21, 2017, 07:16 PM
5AM Partners IV, LLC 10% Owner Nov 21, 2017 Buy $14.00 628,572 8,800,008 3,123,302 Nov 21, 2017, 07:16 PM
ORBIMED ADVISORS LLC 10% Owner Nov 21, 2017 Buy $14.00 833,333 11,666,662 3,409,865 Nov 21, 2017, 07:13 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
5AM Partners IV, LLC 10% Owner 04/11/2022 203,665
5AM Partners IV, LLC 10% Owner 04/11/2022 45,855
5AM Partners IV, LLC 10% Owner 04/11/2022 1,100,480
Khattar Jack A. Director 12/03/2021 19,569
Tucker John H President and CEO 12/03/2021 39,553
RA CAPITAL MANAGEMENT, L.P. 10% Owner 03/12/2021 284,816
RA CAPITAL MANAGEMENT, L.P. 10% Owner 03/15/2021 777,787
Tucker John H President and CEO 06/30/2020 75,720
Schwab Andrew J. 10% Owner 05/26/2020 4,999,994
ORBIMED ADVISORS LLC 10% Owner 05/21/2020 11,999,997
RA CAPITAL MANAGEMENT, L.P. 10% Owner 02/14/2020 2,230,343
RA CAPITAL MANAGEMENT, L.P. 10% Owner 02/14/2020 2,230,343
Tucker John H President and CEO 12/13/2019 26,188
RA CAPITAL MANAGEMENT, LLC 10% Owner 04/11/2019 1,052,627
Agger Mette Kirstine Director 11/21/2017 9,166,668
SCHAEFFER LEONARD D Director 12/19/2017 37,567
SUN PHARMACEUTICAL INDUSTRIES LTD 10% Owner 11/21/2017 5,000,002
Lundbeckfond Invest A/S 10% Owner 11/21/2017 9,166,668
5AM Partners IV, LLC 10% Owner 11/21/2017 366,660
5AM Partners IV, LLC 10% Owner 11/21/2017 8,800,008
ORBIMED ADVISORS LLC 10% Owner 11/21/2017 11,666,662
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
0.01%
1Q
12/31/2021
06/30/2021
0.02%
2Q
12/31/2021
03/31/2021
0.05%
3Q
12/31/2021
12/31/2020
11.33%
4Q
12/31/2021
09/30/2020
15.68%
5Q
12/31/2021
06/30/2020
25.54%
6Q
12/31/2021
03/31/2020
35.28%
7Q
12/31/2021
12/31/2019
47.05%
8Q
12/31/2021
09/30/2019
47.21%
9Q
12/31/2021
06/30/2019
47.23%
10Q
12/31/2021
12/31/2018
47.40%
12Q
12/31/2021
09/30/2018
47.44%
13Q
12/31/2021
06/30/2018
47.51%
14Q
12/31/2021
03/31/2018
47.56%
15Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.01%
1Q
06/30/2021
0.02%
2Q
03/31/2021
0.05%
3Q
12/31/2020
11.33%
4Q
09/30/2020
15.68%
5Q
06/30/2020
25.54%
6Q
03/31/2020
35.28%
7Q
12/31/2019
47.05%
8Q
09/30/2019
47.21%
9Q
06/30/2019
47.23%
10Q
12/31/2018
47.40%
12Q
09/30/2018
47.44%
13Q
06/30/2018
47.51%
14Q
03/31/2018
47.56%
15Q
Load More